ABBOTT LABORATORIES (ABL.DE) Stock Price, Forecast & Analysis
Europe - FRA:ABL - US0028241000 - Common Stock
ABL.DE Key Statistics, Chart & Performance
The current stock price of ABL.DE is 113.02 EUR. In the past month the price increased by 2.21%. In the past year, price increased by 0.87%.
ABL.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 2M6.DE | MEDTRONIC PLC | 17.59 | 107.14B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 21.99 | 47.13B | ||
| 1SHL.MI | SIEMENS HEALTHINEERS AG | 18.38 | 49.34B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.82 | 23.32B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.9 | 23.44B | ||
| BIM.PA | BIOMERIEUX | 27.56 | 12.59B | ||
| AFX.DE | CARL ZEISS MEDITEC AG - BR | 24.21 | 3.70B | ||
| DIA.MI | DIASORIN SPA | 16.96 | 3.29B | ||
| DRW3.DE | DRAEGERWERK AG - PREF | 10.6 | 1.28B | ||
| DRW8.DE | DRAEGERWERK AG | 9.46 | 1.14B | ||
| EUZ.DE | ECKERT & ZIEGLER SE | 27.27 | 1.02B | ||
| ELN.MI | EL.EN. SPA | 17.64 | 905.80M |
Related stock screener links
About ABL.DE
Company Profile
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
Company Info
ABBOTT LABORATORIES
100 Abbott Park Road, Abbot Park
ABBOTT PARK ILLINOIS US
Employees: 114000
Phone: 12246676100
ABBOTT LABORATORIES / ABL.DE FAQ
What does ABL do?
Abbott Laboratories engages in the discovery, development, manufacture, and sale of healthcare products. The company is headquartered in Abbott Park, Illinois and currently employs 114,000 full-time employees. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. The company serves people in more than 160 countries.
What is the current price of ABL stock?
The current stock price of ABL.DE is 113.02 EUR. The price increased by 1.22% in the last trading session.
Does ABL stock pay dividends?
ABBOTT LABORATORIES (ABL.DE) has a dividend yield of 1.83%. The yearly dividend amount is currently 1.9.
How is the ChartMill rating for ABBOTT LABORATORIES?
ABL.DE has a ChartMill Technical rating of 4 out of 10 and a ChartMill Fundamental rating of 7 out of 10.
What sector and industry does ABBOTT LABORATORIES belong to?
ABBOTT LABORATORIES (ABL.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Would investing in ABBOTT LABORATORIES be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on ABL.DE.
Can you provide the market cap for ABBOTT LABORATORIES?
ABBOTT LABORATORIES (ABL.DE) has a market capitalization of 196.71B EUR. This makes ABL.DE a Large Cap stock.
ABL.DE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to ABL.DE. When comparing the yearly performance of all stocks, ABL.DE is a bad performer in the overall market: 64.61% of all stocks are doing better.
ABL.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 7 / 10 to ABL.DE. ABL.DE gets an excellent profitability rating and is at the same time showing great financial health properties.
ABL.DE Financial Highlights
Over the last trailing twelve months ABL.DE reported a non-GAAP Earnings per Share(EPS) of 4.28. The EPS increased by 10.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 31.88% | ||
| ROA | 16.6% | ||
| ROE | 27.43% | ||
| Debt/Equity | 0.23 |
ABL.DE Forecast & Estimates
36 analysts have analysed ABL.DE and the average price target is 126.7 EUR. This implies a price increase of 12.1% is expected in the next year compared to the current price of 113.02.
For the next year, analysts expect an EPS growth of 11.45% and a revenue growth 6.43% for ABL.DE